Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

United Therapeutics

Founders Martine Rothblatt



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
The average size of a deal this fund participated in
Portfolio companies 3
Rounds per year 0.12
Lead investments 0
Key employees Soon

Areas of investment

  • Health Care
  • Health Diagnostics
  • Wireless
  • Medical
  • Education

United Therapeutics appeared to be the Corporate Investor, which was created in 1996. The leading representative office of defined Corporate Investor is situated in the Silver Spring. The fund was located in North America if to be more exact in United States.

This organization was formed by Martine Rothblatt.

Among the most popular portfolio startups of the fund, we may highlight Celularity, Transoma Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Wireless, Health Care.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the United Therapeutics, startups are often financed by Polaris Partners, Canaan Partners, Affinity Capital Management. The meaningful sponsors for the fund in investment in the same round are Tony Robbins, Sorrento Therapeutics, Section 32. In the next rounds fund is usually obtained by National Institutes of Health, American Heart Association.

The top activity for fund was in 2018. The usual things for fund are deals in the range of 50 - 100 millions dollars. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of United Therapeutics:
Typical Co-investors
United Therapeutics is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after United Therapeutics:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Acero Capital California, Menlo Park, United States
Bond Capital British Columbia, Canada, Vancouver
Carrot -
Engagement Commerce Lab Japan, Tokyo
Investec Cape Town, South Africa, Western Cape
Salt Ventures -
Southpoint Capital Advisors New York, New York, United States
Sponsor Capital Finland, Helsinki, Southern Finland
WellSpan Health Pennsylvania, United States, York
Xizang Jiuling Chuangye Touzi Chengguan District, China, Lhasa


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent United Therapeutics?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 91M
Rounds per year 0.12
Peak activity year 2018
Lead investments 0
Group Appearance index 0.67
Crunchbase icon

Content report

The following text will be sent to our editors: